| Obstetrical Opportunities: Will Pharmacy Ever Realize Them? (February). | |
| | |
MedLine Citation:
|
PMID: 22298603 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Based on a survey of the American College of Clinical Pharmacy Women's Health Practice and Research Network and our own experience, the pharmacy profession has limited involvement in obstetric pharmacotherapy. We believe that such involvement in pregnancies with complicated conditions can result in significant improvement of pregnancy outcomes. Moreover, we believe thisinvolvement would be welcomed by the physicians caring for these patients. This commentary documents current obstetrical pharmacy practices and proposes changes for the profession of pharmacy to consider. |
| | |
Authors:
|
Denise Ragland; Gerald G Briggs; Mitzi Wasik; Julie J Kelsey; Ema Ferreira; Wendy Abe-Fukushima; Alicia B Forinash; Brenda D Kelly; Michael P Nageotte |
Related Documents
:
|
744173 - Prolactin binding in pregnancy-dependent mammary tumors in gr/a mice. 3979833 - Optic neuritis during lactation. 8633633 - Receiver-operator characteristic curves for the ultrasonographic prediction of small-fo... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-1-31 |
Journal Detail:
|
Title: The Annals of pharmacotherapy Volume: - ISSN: 1542-6270 ISO Abbreviation: - Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2012-2-2 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9203131 Medline TA: Ann Pharmacother Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Pharmacy Practice, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Tesamorelin: A Growth Hormone-Releasing Factor Analogue for HIV-Associated Lipodystrophy (February).
Next Document: Serum Potassium Influencing Interacting Drugs: Risk-Modifying Strategies Also Needed at Discontinu...